Aptevo Therapeutics

Price & Volume

Stats

See more
52W Range
$1-$109.80
Market Cap
$18.5M
Shares Short
391,017

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
-100%
Gross Profit (12 Mos)
$345,000
Diluted EPS
$1,950.74

About

CEO
Mr. Marvin L. White
CFO
Ms. Daphne L. Taylor CPA
Address
2401 4th Avenue, Seattle, WA, United States, 98121
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
37